Budget Impact Analysis of Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in Specialties Hospital In Ecuador
May 1, 2018, 00:00
10.1016/j.jval.2018.04.136
https://www.valueinhealthjournal.com/article/S1098-3015(18)30436-4/fulltext
Title :
Budget Impact Analysis of Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in Specialties Hospital In Ecuador
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)30436-4&doi=10.1016/j.jval.2018.04.136
First page :
Section Title :
Open access? :
No
Section Order :
727